# Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma

> **NCT00199043** · PHASE3 · COMPLETED · sponsor: **Goethe University** · enrollment: 80 (actual)

## Conditions studied

- Adult Acute Lymphocytic Leukemia
- High-grade Lymphoma

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Rasburicase

## Key facts

- **NCT ID:** NCT00199043
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199043, "Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00199043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*